Literature DB >> 33093097

Susceptibility to severe COVID-19.

David B Beck1, Ivona Aksentijevich2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33093097     DOI： 10.1126/science.abe7591

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  14 in total

1.  Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis.

Authors:  Rafaela Pires da Silva; João Ismael Budelon Gonçalves; Rafael Fernandes Zanin; Felipe Barreto Schuch; Ana Paula Duarte de Souza
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

2.  Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19.

Authors:  Immacolata Andolfo; Roberta Russo; Vito Alessandro Lasorsa; Sueva Cantalupo; Barbara Eleni Rosato; Ferdinando Bonfiglio; Giulia Frisso; Pasquale Abete; Gian Marco Cassese; Giuseppe Servillo; Gabriella Esposito; Ivan Gentile; Carmelo Piscopo; Romolo Villani; Giuseppe Fiorentino; Pellegrino Cerino; Carlo Buonerba; Biancamaria Pierri; Massimo Zollo; Achille Iolascon; Mario Capasso
Journal:  iScience       Date:  2021-03-17

3.  Mitochondria as Targets for Endothelial Protection in COVID-19.

Authors:  Boris V Chernyak; Ekaterina N Popova; Ludmila A Zinovkina; Konstantin G Lyamzaev; Roman A Zinovkin
Journal:  Front Physiol       Date:  2020-11-19       Impact factor: 4.566

Review 4.  Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain.

Authors:  Amelia J McFarland; Muhammad S Yousuf; Stephanie Shiers; Theodore J Price
Journal:  Pain Rep       Date:  2021-01-07

Review 5.  Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19.

Authors:  Holger A Lindner; Sonia Y Velásquez; Manfred Thiel; Thomas Kirschning
Journal:  Front Immunol       Date:  2021-03-03       Impact factor: 7.561

6.  Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.

Authors:  Paul Bastard; Elizaveta Orlova; Leila Sozaeva; Romain Lévy; Alyssa James; Monica M Schmitt; Sebastian Ochoa; Maria Kareva; Yulia Rodina; Adrian Gervais; Tom Le Voyer; Jérémie Rosain; Quentin Philippot; Anna-Lena Neehus; Elana Shaw; Mélanie Migaud; Lucy Bizien; Olov Ekwall; Stefan Berg; Guglielmo Beccuti; Lucia Ghizzoni; Gérard Thiriez; Arthur Pavot; Cécile Goujard; Marie-Louise Frémond; Edwin Carter; Anya Rothenbuhler; Agnès Linglart; Brigite Mignot; Aurélie Comte; Nathalie Cheikh; Olivier Hermine; Lars Breivik; Eystein S Husebye; Sébastien Humbert; Pierre Rohrlich; Alain Coaquette; Fanny Vuoto; Karine Faure; Nizar Mahlaoui; Primož Kotnik; Tadej Battelino; Katarina Trebušak Podkrajšek; Kai Kisand; Elise M N Ferré; Thomas DiMaggio; Lindsey B Rosen; Peter D Burbelo; Martin McIntyre; Nelli Y Kann; Anna Shcherbina; Maria Pavlova; Anna Kolodkina; Steven M Holland; Shen-Ying Zhang; Yanick J Crow; Luigi D Notarangelo; Helen C Su; Laurent Abel; Mark S Anderson; Emmanuelle Jouanguy; Bénédicte Neven; Anne Puel; Jean-Laurent Casanova; Michail S Lionakis
Journal:  J Exp Med       Date:  2021-07-05       Impact factor: 14.307

Review 7.  Adapted sickness behavior - Why it is not enough to limit the COVID-19 spread?

Authors:  Jaouad Bouayed; Torsten Bohn
Journal:  Brain Behav Immun       Date:  2021-01-04       Impact factor: 7.217

Review 8.  COVID-19 in Children.

Authors:  Philip Zachariah
Journal:  Infect Dis Clin North Am       Date:  2021-11-15       Impact factor: 5.982

9.  Oropharyngeal Microbiome Profiled at Admission is Predictive of the Need for Respiratory Support Among COVID-19 Patients.

Authors:  Evan S Bradley; Abigail L Zeamer; Vanni Bucci; Lindsey Cincotta; Marie-Claire Salive; Protiva Dutta; Shafik Mutaawe; Otuwe Anya; Christopher Tocci; Ann Moormann; Doyle V Ward; Beth A McCormick; John P Haran
Journal:  medRxiv       Date:  2022-02-28

10.  Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

Authors:  Donald C Vinh; Laurent Abel; Paul Bastard; Matthew P Cheng; Antonio Condino-Neto; Peter K Gregersen; Filomeen Haerynck; Maria-Pia Cicalese; David Hagin; Pere Soler-Palacín; Anna M Planas; Aurora Pujol; Luigi D Notarangelo; Qian Zhang; Helen C Su; Jean-Laurent Casanova; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-06-08       Impact factor: 8.542
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.